Sugie et al. described a female DD patient with decreased LAMP2 expression and proposed that a 50% reduction in LAMP2 expression may prevent the development of myopathy, but not cardiomyopathy (Sugie et al., 2018). Here, LAMP2 is linked to cardiomyopathy.